Recent studies reported association of NQO1 Pro187Ser polymorphism (rs1800566) with susceptibility to cancers such as gastric and breast cancers [11], [12] as well as with modification of the prognosis of breast cancer treated with anthracycline-based adjuvant chemotherapy [13]. Here, NQO1 is linked to breast carcinoma.